Biotech and Pharmaceuticals
U.S. Covid public health emergency ends, leaving behind a battered health system
A sign outside of a hospital advertises COVID-19 testing on November 19, 2021 in New York City. Spencer Platt | Getty Images The U.S. public health emergency declared in response to Covid-19 comes to an end Thursday more than three years after the pandemic began. The Biden administration’s decision to end the emergency comes as […]
Read More
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Eli Lilly CEO Dave Ricks on Wednesday promised not to raise prices on the company’s existing insulin products again — the only executive to do so before a Senate Health Committee hearing on making the life-saving diabetes drug more affordable. Sen. Bernie Sanders, the committee’s chair, asked Ricks and the CEOs of Novo Nordisk and […]
Read More
FDA advisors recommend sale of birth control pill without a prescription
Opill Oral Contraception Source: Perrigo A panel of experts who advise the Food and Drug Administration unanimously recommended Wednesday that the agency for the first time allow women to obtain a birth control pill without a prescription. The panel had been asked whether the benefits of selling HRA Pharma’s birth control pill Opill outweighed the […]
Read More
Breast cancer screenings should start at age 40 instead of 50, U.S. panel says
Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images Most women should get screened for breast cancer every other year starting at age 40, a decade earlier than previously recommended, according to draft guidelines issued Tuesday by a government-backed panel of […]
Read More
Gilead Sciences defeats U.S. government lawsuit alleging HIV drug patent violations
The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters A Delaware federal court jury on Tuesday cleared Gilead Sciences of civil claims by the U.S. government that the company violated patents held by the Centers for Disease and Prevention for an HIV prevention drug. The […]
Read More
FDA may allow birth control pill without prescription this summer as experts weigh data
Opill Oral Contraception Source: Perrigo The Food and Drug Administration could approve the sale of birth control medication without a prescription for the first time by this summer. A committee of independent experts who advise the FDA is set to meet Tuesday and Wednesday to make a recommendation on whether data submitted by HRA Pharma […]
Read More
Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Shares of Novavax rose 5% in premarket trading Tuesday after the company unveiled promising new vaccine data and a […]
Read More
CDC Director Rochelle Walensky will resign in June
Director of the Centers for Disease Control Rochelle Walensky departs after testifying before the Senate Committee on Health, Education, Labor and Pensions on the All-Hazards Preparedness Act at the Dirksen Senate Office Building on Thursday, May 4, 2023 in Washington, DC. Kent Nishimura | Los Angeles Times | Getty Images CDC Director Dr. Rochelle Walensky […]
Read More
CDC will have less data to track Covid and new variants after public health emergency ends
People walk by a Covid-19 testing site at Times Square on May 12, 2022 in New York City. Liao Pan | China News Service | Getty Images The Centers for Disease Control and Prevention will have less data to track the spread of Covid-19 and new variants in the U.S. after the public health emergency […]
Read More
Kenvue CEO looks to brand, product innovation to drive growth after IPO
Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson consumer-health business, speaks during an interview with CNBC during his company’s IPO at the New York Stock Exchange (NYSE), May 4, 2023. Brendan McDermid | Reuters Kenvue CEO Thibaut Mongon is betting on brand and product innovation to drive growth at the newly spun-out company […]
Read More